An Evaluation of Pharmacokinetics and Pharmacodynamics of Leuprorelin Acetate 3M-Depot in Patients with Advanced and Metastatic Carcinoma of the Prostate

Publisher： Karger

E-ISSN： 1423-0399|60|1|33-40

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.60, Iss.1, 1998-02, pp. : 33-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results

By  

Urologia Internationalis, Vol. 60, Iss. 2, 1998-04 ,pp. : 18-24

Karger

Access to resources Recommend Favorite

Comparison of LH-RH Analogue 1-Month Depot and 3-Month Depot by Their Hormone Levels and Pharmacokinetic Profile in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 1, 1998-03 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

Effect of a new leuprorelin formulation on testosterone levels in patients with advanced prostate cancer

By Berges R.   Bello U.  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 649-655

Informa Healthcare

Access to resources Recommend Favorite

3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial

By  

Urologia Internationalis, Vol. 70, Iss. 4, 2003-05 ,pp. : 316-320

Karger

Access to resources Recommend Favorite

Leuprorelin 1-Month Depot as Neoadjuvant Therapy for Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 2, 1998-04 ,pp. : 11-17

Karger

Access to resources Recommend Favorite